EFFICACY AND SAFETY OF 108 WEEKS' BIMEKIZUMAB TREATMENT IN PATIENTS WITH PSORIATIC ARTHRITIS: INTERIM RESULTS FROM A PHASE 2 OPEN-LABEL EXTENSION STUDY

被引：0
|
作者：
Mcinnes, I. [1 ]
Merola, J. F. [2 ]
Mease, P. J. [3 ,4 ]
Coates, L. C. [5 ]
Joshi, P. [6 ]
Coarse, J. [7 ]
Ink, B. [6 ]
Ritchlin, C. T. [8 ]
机构：
[1] Univ Glasgow, Glasgow, Lanark, Scotland
[2] Harvard Med Sch, Brigham & Womens Hosp, Boston, MA 02115 USA
[3] Swedish Med Ctr, Seattle, WA USA
[4] Univ Washington, Seattle, WA 98195 USA
[5] Univ Oxford, Oxford, England
[6] UCB Pharma, Slough, Berks, England
[7] UCB Pharma, Raleigh, NC USA
[8] Univ Rochester, Med Ctr, Rochester, NY 14642 USA
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2020年 / 79卷
关键词：
D O I：
10.1136/annrheumdis-2020-eular.1850
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
SAT0403
引用
收藏
页码：1149 / 1150
页数：2
相关论文
共 50 条
  • [1] Efficacy and Safety of 108 Weeks of Bimekizumab Treatment in Patients with Psoriatic Arthritis: Interim Results from a Phase 2 Open-Label Extension Study
    McInnes, I. B.
    Merola, J. F.
    Mease, P. J.
    Coates, L. C.
    Schmitz, N.
    Joshi, P.
    Coarse, J.
    Ink, B.
    Ritchlin, C. T.
    [J]. SWISS MEDICAL WEEKLY, 2020, : 7S - 8S
  • [2] Bimekizumab Safety and Efficacy in Patients with Psoriatic Arthritis: 3-Year Results from a Phase 2b Open-Label Extension Study
    Coates, L. C.
    Warren, R. B.
    Ritchlin, C. T.
    Gossec, L.
    Merola, J. F.
    Assudani, D.
    Coarse, J.
    Eells, J.
    Ink, B.
    McInnes, I. B.
    [J]. SWISS MEDICAL WEEKLY, 2021, 151 : S20 - S20
  • [3] BIMEKIZUMAB SAFETY AND EFFICACY IN PATIENTS WITH PSORIATIC ARTHRITIS: 3-YEAR RESULTS FROM A PHASE 2B OPEN-LABEL EXTENSION STUDY
    Coates, L. C.
    Warren, R. B.
    Ritchlin, C. T.
    Gossec, L.
    Merola, J. F.
    Assudani, D.
    Coarse, J.
    Eells, J.
    Ink, B.
    Mcinnes, I.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 779 - 780
  • [4] Bimekizumab Long-Term Efficacy and Safety over 96 Weeks in Patients with Ankylosing Spondylitis: Interim Results from a Phase 2b Open-Label Extension Study
    Baraliakos, Xenofon
    Deodhar, Atul
    Dougados, Maxime
    Oortgiesen, Marga
    de Peyrecave, Natasha
    Bauer, Martin
    Vaux, Thomas
    Fleurinck, Carmen
    van der Heijde, Desiree
    [J]. ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [5] Safety and Efficacy of Bimekizumab in Patients With Active Psoriatic Arthritis: Three-Year Results From a Phase IIb Randomized Controlled Trial and Its Open-Label Extension Study
    Coates, Laura C.
    McInnes, Iain B.
    Merola, Joseph F.
    Warren, Richard B.
    Kavanaugh, Arthur
    Gottlieb, Alice B.
    Gossec, Laure
    Assudani, Deepak
    Bajracharya, Rajan
    Coarse, Jason
    Ink, Barbara
    Ritchlin, Christopher T.
    [J]. ARTHRITIS & RHEUMATOLOGY, 2022, 74 (12) : 1959 - 1970
  • [6] EFFICACY AND SAFETY AFTER 64 WEEKS OF IXEKIZUMAB TREATMENT IN A PHASE 2 OPEN LABEL EXTENSION STUDY IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Genovese, M.
    Carlier, H.
    Erickson, J.
    Braun, D.
    Banerjee, S.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 616 - 616
  • [7] Bimekizumab Maintenance of Response in Patients with Psoriatic Arthritis: 2-Year Results from a Phase 2b Dose-Ranging Study and Its Open-Label Extension
    Merola, Joseph
    Behrens, Frank
    Kivitz, Alan
    Mease, Philip
    McInnes, Iain
    Ink, Barbara
    Assudani, Deepak
    Joshi, Paulatsya
    Coarse, Jason
    Ritchlin, Christopher
    [J]. ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [8] Safety and Efficacy of Tofacitinib in Patients with Active Psoriatic Arthritis: Interim Analysis of OPAL Balance, an Open-Label, Long-Term Extension Study
    Nash, Peter
    Coates, Laura C.
    Kivitz, Alan
    Mease, Philip J.
    Gladman, Dafna D.
    Covarrubias-Cobos, Jose A.
    Fitzgerald, Oliver
    Fleishaker, Dona
    Wang, Cunshan
    Wu, Joseph
    Hsu, Ming-Ann
    Menon, Sujatha
    Fallon, Lara
    Romero, Ana Belen
    Kanik, Keith S.
    [J]. RHEUMATOLOGY AND THERAPY, 2020, 7 (03) : 553 - 580
  • [9] Safety and Efficacy of Tofacitinib in Patients with Active Psoriatic Arthritis: Interim Analysis of OPAL Balance, an Open-Label, Long-Term Extension Study
    Peter Nash
    Laura C. Coates
    Alan J. Kivitz
    Philip J. Mease
    Dafna D. Gladman
    José A. Covarrubias-Cobos
    Oliver FitzGerald
    Dona Fleishaker
    Cunshan Wang
    Joseph Wu
    Ming-Ann Hsu
    Sujatha Menon
    Lara Fallon
    Ana Belén Romero
    Keith S. Kanik
    [J]. Rheumatology and Therapy, 2020, 7 : 553 - 580
  • [10] BIMEKIZUMAB IN PATIENTS WITH PSORIATIC ARTHRITIS: ACHIEVEMENT AND MAINTENANCE OF PSORIATIC ARTHRITIS RESPONSE CRITERIA RESPONSES THROUGH 3 YEARS IN A PHASE 2B OPEN-LABEL EXTENSION STUDY
    Tillett, William
    McInnes, Iain B.
    McGonagle, Dennis
    Jadon, Deepak R.
    Ink, Barbara
    Assudani, Deepak
    Coarse, Jason
    Eells, Jason
    Coates, Laura C.
    [J]. RHEUMATOLOGY, 2022, 61 : I20 - I20
12345